why choose us

Course: Emergency Use Authorizations of COVID-19–Related Medical Products

CME Credits: 1.00

Released: 2021-12-20

Emergency use authorization (EUA) enables the US Food and Drug Administration (FDA) to facilitate the availability of medical countermeasures when public health emergencies are declared by the secretary of the US Department of Health and Human Services. Few medical products were authorized for 15 years after the first EUA for an anthrax vaccine was issued in February 2005. During the COVID-19 crisis, EUA was used extensively for rapid authorizations of medical products. In this study, we examined the COVID-19–related products authorized by the FDA and the quality of their supporting evidence.


Educational Objective
To identify the key insights or developments described in this article


View Full Course